Skip to main content
Clinical Trials/NCT05630716
NCT05630716
Completed
N/A

Pilot Evaluation Using The Non-Invasive Cardiac Output Monitor (NICOM) for Goal-directed Fluid Resuscitation for Inpatients With Hypotension and/or Septic Shock

University of Minnesota1 site in 1 country251 target enrollmentJuly 31, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Sepsis
Sponsor
University of Minnesota
Enrollment
251
Locations
1
Primary Endpoint
ICU length of stay
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

The Non-Invasive Cardiac Output Monitor (NICOM) is a non-invasive monitor capable of measuring cardiac output (CO) and cardiac index (CI), and stroke volume (SV) and stroke volume index (SVI) based on heart rate. Conceptually NICOM is a technology that utilizes a dynamic response characteristic in assessing the need for fluid administration, whereby SVI is measured before and after a fluid challenge with more fluid given only if SVI increases significantly with administered fluid. Dynamic response technologies are intended to replace older, "static" measures such as central venous pressure (CVP) and pulmonary capillary wedge pressures (PCWP) which are single point measurements utilized to assess the need to administer fluid.

The aim is to pilot and evaluate the effectiveness of using The Non-Invasive Cardiac Output Monitor (NICOM) technology for goal-directed fluid resuscitation in adult inpatients with sepsis associated acute hypotension and/or evidence of septic shock (Lactate >= 4.0).

Registry
clinicaltrials.gov
Start Date
July 31, 2023
End Date
May 31, 2025
Last Updated
8 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All adult patients \> 18 years of age
  • inpatients for \>/= 6 hours
  • meeting criteria for sepsis as defined by hypotension related to sepsis (MAP \< 65 or SBP \< 90) or evidence of septic shock (Lactate ≥ 4.0).

Exclusion Criteria

  • Patients who die within 24 hours of hospital admission
  • patients documented as "comfort cares" or enrolled in "general inpatient hospice" during the first 72 hours of hospitalization.
  • opted out of having their medical information used in research, as noted in the EHR.

Outcomes

Primary Outcomes

ICU length of stay

Time Frame: 18 months post-treatment

Hospital length of stay

Time Frame: 18 months post-treatment

Hospital mortality

Time Frame: 18 months post-treatment

Secondary Outcomes

  • Difference in positive fluid balance at 75 hours of ICU discharge(75 hours post treatment ( ICU discharge))
  • Hours of vasopressor use(18 months post-treatment)
  • change from baseline serum creatinine(18 months post-treatment)

Study Sites (1)

Loading locations...

Similar Trials